Cargando…

Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats

AIMS/HYPOTHESIS: Genetic studies show coupling of genes affecting beta cell function to type 1 diabetes, but hitherto no studies on whether beta cell dysfunction could precede insulitis and clinical onset of type 1 diabetes are available. METHODS: We used 40-day-old BioBreeding (BB) DRLyp/Lyp rats (...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina, Anya, Parween, Saba, Ullsten, Sara, Vishnu, Neelanjan, Siu, Yuk Ting, Quach, My, Bennet, Hedvig, Balhuizen, Alexander, Åkesson, Lina, Wierup, Nils, Carlsson, Per Ola, Ahlgren, Ulf, Lernmark, Åke, Fex, Malin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448977/
https://www.ncbi.nlm.nih.gov/pubmed/29209740
http://dx.doi.org/10.1007/s00125-017-4512-z
_version_ 1783408768962265088
author Medina, Anya
Parween, Saba
Ullsten, Sara
Vishnu, Neelanjan
Siu, Yuk Ting
Quach, My
Bennet, Hedvig
Balhuizen, Alexander
Åkesson, Lina
Wierup, Nils
Carlsson, Per Ola
Ahlgren, Ulf
Lernmark, Åke
Fex, Malin
author_facet Medina, Anya
Parween, Saba
Ullsten, Sara
Vishnu, Neelanjan
Siu, Yuk Ting
Quach, My
Bennet, Hedvig
Balhuizen, Alexander
Åkesson, Lina
Wierup, Nils
Carlsson, Per Ola
Ahlgren, Ulf
Lernmark, Åke
Fex, Malin
author_sort Medina, Anya
collection PubMed
description AIMS/HYPOTHESIS: Genetic studies show coupling of genes affecting beta cell function to type 1 diabetes, but hitherto no studies on whether beta cell dysfunction could precede insulitis and clinical onset of type 1 diabetes are available. METHODS: We used 40-day-old BioBreeding (BB) DRLyp/Lyp rats (a model of spontaneous autoimmune type 1 diabetes) and diabetes-resistant DRLyp/+ and DR+/+ littermates (controls) to investigate beta cell function in vivo, and insulin and glucagon secretion in vitro. Beta cell mass was assessed by optical projection tomography (OPT) and morphometry. Additionally, measurements of intra-islet blood flow were performed using microsphere injections. We also assessed immune cell infiltration, cytokine expression in islets (by immunohistochemistry and qPCR), as well as islet Glut2 expression and ATP/ADP ratio to determine effects on glucose uptake and metabolism in beta cells. RESULTS: DRLyp/Lyp rats were normoglycaemic and without traces of immune cell infiltrates. However, IVGTTs revealed a significant decrease in the acute insulin response to glucose compared with control rats (1685.3 ± 121.3 vs 633.3 ± 148.7; p < 0.0001). In agreement, insulin secretion was severely perturbed in isolated islets, and both first- and second-phase insulin release were lowered compared with control rats, while glucagon secretion was similar in both groups. Interestingly, after 5–7 days of culture of islets from DRLyp/Lyp rats in normal media, glucose-stimulated insulin secretion (GSIS) was improved; although, a significant decrease in GSIS was still evident compared with islets from control rats at this time (7393.9 ± 1593.7 vs 4416.8 ± 1230.5 pg islet(−1) h(−1); p < 0.0001). Compared with controls, OPT of whole pancreas from DRLyp/Lyp rats revealed significant reductions in medium (4.1 × 10(9) ± 9.5 × 10(7) vs 3.8 × 10(9) ± 5.8 × 10(7) μm(3); p = 0.044) and small sized islets (1.6 × 10(9) ± 5.1 × 10(7) vs 1.4 × 10(9) ± 4.5 × 10(7) μm(3); p = 0.035). Finally, we found lower intra-islet blood perfusion in vivo (113.1 ± 16.8 vs 76.9 ± 11.8 μl min(−1) [g pancreas](−1); p = 0.023) and alterations in the beta cell ATP/ADP ratio in DRLyp/Lyp rats vs control rats. CONCLUSIONS/INTERPRETATION: The present study identifies a deterioration of beta cell function and mass, and intra-islet blood flow that precedes insulitis and diabetes development in animals prone to autoimmune type 1 diabetes. These underlying changes in islet function may be previously unrecognised factors of importance in type 1 diabetes development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-017-4512-z) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-6448977
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-64489772019-04-17 Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats Medina, Anya Parween, Saba Ullsten, Sara Vishnu, Neelanjan Siu, Yuk Ting Quach, My Bennet, Hedvig Balhuizen, Alexander Åkesson, Lina Wierup, Nils Carlsson, Per Ola Ahlgren, Ulf Lernmark, Åke Fex, Malin Diabetologia Article AIMS/HYPOTHESIS: Genetic studies show coupling of genes affecting beta cell function to type 1 diabetes, but hitherto no studies on whether beta cell dysfunction could precede insulitis and clinical onset of type 1 diabetes are available. METHODS: We used 40-day-old BioBreeding (BB) DRLyp/Lyp rats (a model of spontaneous autoimmune type 1 diabetes) and diabetes-resistant DRLyp/+ and DR+/+ littermates (controls) to investigate beta cell function in vivo, and insulin and glucagon secretion in vitro. Beta cell mass was assessed by optical projection tomography (OPT) and morphometry. Additionally, measurements of intra-islet blood flow were performed using microsphere injections. We also assessed immune cell infiltration, cytokine expression in islets (by immunohistochemistry and qPCR), as well as islet Glut2 expression and ATP/ADP ratio to determine effects on glucose uptake and metabolism in beta cells. RESULTS: DRLyp/Lyp rats were normoglycaemic and without traces of immune cell infiltrates. However, IVGTTs revealed a significant decrease in the acute insulin response to glucose compared with control rats (1685.3 ± 121.3 vs 633.3 ± 148.7; p < 0.0001). In agreement, insulin secretion was severely perturbed in isolated islets, and both first- and second-phase insulin release were lowered compared with control rats, while glucagon secretion was similar in both groups. Interestingly, after 5–7 days of culture of islets from DRLyp/Lyp rats in normal media, glucose-stimulated insulin secretion (GSIS) was improved; although, a significant decrease in GSIS was still evident compared with islets from control rats at this time (7393.9 ± 1593.7 vs 4416.8 ± 1230.5 pg islet(−1) h(−1); p < 0.0001). Compared with controls, OPT of whole pancreas from DRLyp/Lyp rats revealed significant reductions in medium (4.1 × 10(9) ± 9.5 × 10(7) vs 3.8 × 10(9) ± 5.8 × 10(7) μm(3); p = 0.044) and small sized islets (1.6 × 10(9) ± 5.1 × 10(7) vs 1.4 × 10(9) ± 4.5 × 10(7) μm(3); p = 0.035). Finally, we found lower intra-islet blood perfusion in vivo (113.1 ± 16.8 vs 76.9 ± 11.8 μl min(−1) [g pancreas](−1); p = 0.023) and alterations in the beta cell ATP/ADP ratio in DRLyp/Lyp rats vs control rats. CONCLUSIONS/INTERPRETATION: The present study identifies a deterioration of beta cell function and mass, and intra-islet blood flow that precedes insulitis and diabetes development in animals prone to autoimmune type 1 diabetes. These underlying changes in islet function may be previously unrecognised factors of importance in type 1 diabetes development. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-017-4512-z) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2017-12-06 2018 /pmc/articles/PMC6448977/ /pubmed/29209740 http://dx.doi.org/10.1007/s00125-017-4512-z Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Medina, Anya
Parween, Saba
Ullsten, Sara
Vishnu, Neelanjan
Siu, Yuk Ting
Quach, My
Bennet, Hedvig
Balhuizen, Alexander
Åkesson, Lina
Wierup, Nils
Carlsson, Per Ola
Ahlgren, Ulf
Lernmark, Åke
Fex, Malin
Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats
title Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats
title_full Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats
title_fullStr Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats
title_full_unstemmed Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats
title_short Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats
title_sort early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in biobreeding rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448977/
https://www.ncbi.nlm.nih.gov/pubmed/29209740
http://dx.doi.org/10.1007/s00125-017-4512-z
work_keys_str_mv AT medinaanya earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT parweensaba earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT ullstensara earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT vishnuneelanjan earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT siuyukting earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT quachmy earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT bennethedvig earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT balhuizenalexander earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT akessonlina earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT wierupnils earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT carlssonperola earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT ahlgrenulf earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT lernmarkake earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats
AT fexmalin earlydeficitsininsulinsecretionbetacellmassandisletbloodperfusionprecedeonsetofautoimmunetype1diabetesinbiobreedingrats